Boston Scientific pledges $100,000 to SIR Foundation's Discovery Campaign

NewsGuard 100/100 Score

The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Boston Scientific, a global leader in medical devices for cardiovascular and peripheral interventions, pledged $100,000 and is a "Pioneer" level supporter.

"The impact that corporate support at this level has on the future of the specialty is immense," said Gordon McLennan, M.D., FSIR, chair of the SIR Foundation board of directors. "This funding will accelerate pioneering work in interventional radiology in the form of grants, research consensus panels, registries, clinical trials and educational programming. Support of this kind sends a clear message about investing in the future of an innovative specialty like interventional radiology and enabling research that leads into promising new directions," noted McLennan, an interventional radiologist with the Cleveland Clinic in Cleveland, Ohio. "We thank Boston Scientific for coming forward to support us on this venture," he noted.

"Boston Scientific has been a long-term supporter of the interventional radiology community, and we are excited by this education and research initiative dedicated to advancing minimally invasive medicine," said Jeff Mirviss, president of the peripheral interventions division at Boston Scientific. 

Source: Society of Interventional Radiology

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rising antibiotic resistance prompts shift to ecological research strategies in infection control